白皮书
Master Data Management
The foundation of excellence in customer engagement
May 08, 2019
By submitting this form you agree to our使用条款and隐私政策. Information provided by you may be collected and automatically stored in our database and may be used for sending you additional information about IQVIA and our services. Such information also may be transferred to IQVIA companies in other countries. Copyright © 2018-2022 IQVIA Holdings Inc. and its affiliates. All rights reserved.

This white paper addresses how the rise of commercial and regulatory complexity demands accurate master data. The commercial environment for pharmaceutical companies is challenged. The challenge is a growing stakeholder complexity, which must be managed better, but no increase in, or reduction in, selling, general and administrative costs.

制药公司的商业环境受到挑战。挑战是越来越多的利益相关者的复杂性,必须更好地管理,但不会增加甚至减少销售,一般和行政成本。

在制药市场和大多数发射的大部分价值增长的环境中,主要的处方者现在是利益相关者和有影响力者越来越复杂的网络之一。患者受到多个医疗保健专业人员(HCP)的照顾,包括专家,初级保健医生,lol买外围用什么软件护士,药剂师以及患者协会和支持小组。lol买外围用什么软件医疗保健专业人员可以在医院和护理环境之间移动。产品通常是多刻板的,可以用多种产品治疗个别患者。所有这些复杂性都可以加速制药公司客户数据库中医疗专业人员多种身份的潜力。lol买外围用什么软件

In parallel, digital dialogue across all stakeholders has arrived, multiplying the contact points and ways that messages can be delivered to a single customer. Further, pharmaceutical companies themselves see greater complexity in their commercial function, with the movement to a customer facing team containing multiple roles, including sales reps, Key Account managers, health economic specialists, nurses, dedicated virtual reps, service reps and Medical Science Liaison officers1 (figure 1). Again, multiple individuals and contact points create the potential for multiple overlapping identities for healthcare professionals and other stakeholders.

下载以阅读更多

Related solutions